Ultimately, your doctor alone has the last say in whether or not a medicine is right for you
Regarding safety, our investigation revealed a dose-dependent escalation in gastrointestinal adverse events, with a notably higher incidence among Asians compared to non-Asians
These results develop over several months, making semaglutide well-suited to patients pursuing gradual, sustainable weight loss backed by an established long-term safety profile
Metformin : Metformin is a type of drug called sulfonylurea, which lowers blood sugar
doi: 10.1136/bmjdrc-2020-002083 54 MeurotCJacquesCMartinCSudreLBretonJRattenbachRet al
GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight/obesity